HIMS
Hims & Hers Health, Inc.
stock NYSE

1. $IREN
2. $HIMS
3. $ONDS
4. $UAMY
5. $TE
6. $PATH
7. $POET
8. $ZETA
9. $EOSE
10. $OUST

The CAC payback + long-term operating leverage angle is the key thing most people overlook. One thing that’s helped me with names like HIMS is using AI to run quick bull/base/bear cases on subs, margins, and dilution - it makes it way easier to see where the real risk is vs just headline noise. Definitely adds clarity before sizing a position.

HIMS Might be Undervalued by ~ 20%

HIMS is making all their pills look like E on their ads 

My biggest wins came from DKNG, HIMS, FUBO, UVXY, PLTR and CNC.

OP made some good calls, HIMS, GOOG, etc.
but he advised SNAP and TE a couple months ago and was completely wrong (well TE has moved up a bit in the last week or two but that's it)
imo he's 50/50 now, which is no better than a coin flip. Take this post with a grain of salt.

Not retired, just hit 50....accomplishing a siginifcant re-balance.
my effective new stance (I was very passive the past few years)
\- 60/40 Growth to income/value (currently at 20/80, uggh)
\- generate 30/per year on income
\- Watch for NAV erosion on ETF's
\- accumulate on strong pullbacks
\- diversify through sections
Just shed a few items $USB and $TFC and picked up $IREN $HIMS $NBIS along with $BTCI $MAGY and fortified $QQQI and $SPYI
Took some high-risk flyers on $POET $HOOY
Open for constructive commentary

I think it’s time to start selling puts in HIMS. I’m also considering SOFI and INTC. Maybe an AAPL Iron Condor or butterfly. Maybe a small position in NKE to see what happens with Tim.

$SMCI $HIMS $HOOD & $NVDA
$BULL if you have high risk tolerance

HIMS for sure. i expect it to triple in 2026, if not more due to the ridiculous short interest

HIMS. undervalued, growing company.

HIMS is definitely going to double or triple in 2026.
Potential NVO partnership + many rumours about the FDA allowing peptides compounding (and hims is the only telehealth company with a peptide compounding facility).
Also, they already announced labs + europe expansion + canada expansion + much more
They have been on an uptrend for a few years now, with higher highs, and higher lows, with 65-70 dollar range being a huge resistance.
The past 2 months it has declined 50%, which happened many many times before, and it recovered each time, this time is no different.
Also, institutional ownership is at an all time high, and the short interest is like 30-35 percent, which is absolutely insane for a company that has been growing year after year.
I believe hims is going to have a strong 2026, potentially going parabolic and breaking that resistance range.

Bro you need $HIMS

Got active in my investment account last year after being a lurker here for a long time.
Big gains shares - adding funds and buying during liberation day correction, buying back dips on HIMS and selling on runs, buying shares on RKLB on the recent dip.
Options losses - was down big then changed strategy, buy the dip strategy worked until it didn’t.
Good luck in the new year!!

$HIMS and $NBIS are the future. I’m from 2028. Enjoy degenerates.

https://preview.redd.it/lw282p1k7w9g1.jpeg?width=1179&format=pjpg&auto=webp&s=97c018062016bcc7dd224328dce6df8831e83f1b
The chart for HIMS & HERS HEALTH I Class A appears to be forming the right side of a potential Cup and Handle, or at minimum, is undergoing a significant retracement after a strong uptrend. The price has pulled back from a high of approximately $72.98, and is currently testing a significant support level around $30-$34. This retracement on lower volume, following a prior strong advance, suggests that sellers may be exhausting, and buyers could step in. The overall structure, with a rounded bottom and subsequent decline, aligns with the 'handle' formation of a Cup and Handle, indicating a potential continuation of the prior uptrend once consolidation is complete. A break above the resistance formed by the top of the handle would confirm a bullish breakout.